Featured Press Releases

HemoSonics

HemoSonics' Quantra® Hemostasis System

Setting a New Standard for End-to-End Traceability and Data Integrity, Waters Enhances Alliance iS HPLC System Software.

Setting a New Standard for End-to-End Traceability and Data Integrity, Waters Enhances Alliance iS HPLC System Software.

  • 18 Jun 2025

High-Performance Liquid Phase Separations and Related Techniques - Waters Corporation (NYSE: WAT)...

Orthofix Receives FDA 510(k) Clearance for Rodeo™ Telescopic Nail

Orthofix Receives FDA 510(k) Clearance for Rodeo™ Telescopic Nail

Xencor Announces Promising Early Results for XmAb942 in First-in-Human Study Targeting IBD

Xencor Announces Promising Early Results for XmAb942 in First-in-Human Study Targeting IBD

Pyros Pharma announces VIGPODER™ (vigabatrin)

Pyros Pharma announces VIGPODER™ (vigabatrin)

Marius Pharmaceuticals Expands Men

Marius Pharmaceuticals Expands Men's Health Solutions by Announcing the Availability of KYZATREX® (testosterone undecanoate) CIII Capsules Through Thrive

Prestigious Journal of Hematology & Oncology Accepts HanchorBio’s Novel CD47-SIRPα Therapeutic, HCB101, for Publication

Prestigious Journal of Hematology & Oncology Accepts HanchorBio’s Novel CD47-SIRPα Therapeutic, HCB101, for Publication

  • HanchorBio Inc.
  • 23 Oct 2025
Mexico’s First Pharmaceutical Company, IFA Celtics, Deploys ForgeStop

Mexico’s First Pharmaceutical Company, IFA Celtics, Deploys ForgeStop's NFC Anti-Counterfeit Tech

  • ForgeStop Technology Corp
  • 23 Oct 2025
Alcami to expand lab services at Durham, NC facility to meet rising biologics demand

Alcami to expand lab services at Durham, NC facility to meet rising biologics demand

  • Alcami
  • 22 Oct 2025
ADARx doses first patient in Phase 3 STOP-HAE trial; ADX-324 receives orphan drug designation for hereditary angioedema

ADARx doses first patient in Phase 3 STOP-HAE trial; ADX-324 receives orphan drug designation for hereditary angioedema

  • ADARx Pharmaceuticals
  • 22 Oct 2025
To drive global expansion of digital chemistry and discovery, Chemify raises over $50 million in an oversubscribed Series B round

To drive global expansion of digital chemistry and discovery, Chemify raises over $50 million in an oversubscribed Series B round

  • Chemify
  • 21 Oct 2025
Successfully deployed in Myanmar conflict zone, the SurgiField system enables life-saving surgery

Successfully deployed in Myanmar conflict zone, the SurgiField system enables life-saving surgery

  • SurgiBox Inc
  • 16 Oct 2025

Most Popular
October   2025
M T W T F S S
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

User Area

Discover

Engage with Us

© 2024 Pharmaceutical Era — A product of HISSM. All Rights Reserved.